Prognostic factors for pulmonary metastasectomy in the treatment of hepatocellular carcinoma

Journal of Thoracic Oncology

Volumn 5, Issue 8, 2010, Pages 1251-1254

  Cho, Sukki ^a   Ryu, Kyung Min ^b   Hwang, Yoon Jin ^a   Lee, Eung Bae ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Dankook University   (South Korea)

Author keywords

hepatocellular carcinoma; prognostic factor; Pulmonary metastasis

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B ANTIGEN; HEPATITIS C ANTIBODY;

ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EVALUATION; CONFIDENCE INTERVAL; DISEASE FREE INTERVAL; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; LIVER CELL CARCINOMA; LOBECTOMY; LUNG METASTASIS; LUNG RESECTION; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; VIRUS HEPATITIS;

EID: 77955096778     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181e2fc9b     Document Type: Article

References (21)

1. Korea National Statistical Office. Annual Report on the Cause of Death Statistics of 2005, Seoul, 2006.
2. Lee PH, Lin WJ, Tsang YM, et al. Clinical management of recurrent hepatocellular carcinoma. Ann Surg 1995;222:670-676.
3. Shimada M, Takenaka K, Gion T, et al. Prognosis of recurrent hapato- cellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 1996;111:720-726.
4. Farges O, Regimbeau JM, Belghiti J. Aggressive management of recurrence following surgical resection of hepatocellular carcinoma. Hepato- gastroenterology 1998;45:1275-1280.
5. Poon RTP, Fan ST, Lo CM, et al. Intrahepatic recurrence after curative resection of hepatocellular carcinoma. Long-term results of treatment and prognostic factors. Ann Surg 1999;229:216-222.
6. Bates MJ, Farkas E, Taylor D, et al. Pulmonary resection of metastatic hepatocellular carcinoma after liver transplantation. Ann Thorac Surg 2008;85:412-415.
7. Mnedez-Sanchez N, Vasquez-Fernandez F, Zamora-Valdes D, et al. Sorafenib, systemic therapy for hepatocellular carcinoma. Ann Hepatol 2008;7:46-51.
8. Lam CM, Lo CM, Yuen WK, et al. Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg 1998;85:1198-2000.
9. Tominaru Y, Sasaki Y, Yamada T, et al. The significance of surgical resection for pulmonary metastasis from hepatocellular carcinoma. Am J Surg 2006;192:46-51.
10. Nakagawa T, Kamiyama T, Nakanishi K, et al. Pulmonary resection for metastases from hepatocellular carcinoma: factors influencing prognosis. J Thorac Cardiovasc Surg 2006;131:1248-1254.
11. Ikai I, Arii S, Kojiro M, et al. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer 2004;101:796-802.
12. Itoh Y, Ohkubo K, Iuchi H, et al. Chronological changes of causes of death and distant metastasis in hepatocellular carcinoma. Oncol Rep 2002;9:331-335.
13. Kuo SW, Chang YL, Huang PM, et al. Prognostic factors for pulmonary metastasectomy in hepatocellular carcinoma. Ann Surg Oncol 2007;14: 992-997.
14. Gwak GY, Jung JO, Sung SW, et al. Long-term survival after pulmonary metastasectomy of hepatocellular carcinoma: treatment outcome or natural history? Hepatogastroenterology 2004;51:1428-1433.
15. Chen F, Sato K, Fujinaga T, et al. Pulmonary resection for metastasis from hepatocellular carcinoma. World J Surg 2008;32:2213-2217.
16. Kwon JB, Park K, Kim YD, et al. Clinical outcome after pulmonary metastasectomy from primary hepatocellular carcinoma: analysis of prognostic factors. World J Gastroenterol 2008;14:5717-5722.
17. Pastorino U, Buyse M, Friedel G, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 1997;113:37-49.
18. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230:309-318.
19. Zhou L, Liu J, Luo F. Serum tumor markers for detection of hepatocel- lular carcinoma. World J Gastroenterol 2006;12:1175-1181.
20. Cancer of the Liver Italian program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 1998;28:751-755.
21. Han SJ, Yoo S, Choi SH, et al. Actual half-life of alpha-fetoprotein as a prognostic tool in pediatric malignant tumors. Pediatr Surg Int 1997;12: 599-602.